retatrutide trial news today Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v Retatrutide Results: 28.3% Weight Loss

Consider these delicious options: zucchini (36 mg

Walk, stretch, lift a little

Watch: GLP-1 hair loss explained This short medical explainer covers the likely cause, the usual shedding timeline, and the practical next steps if your hair starts thinning on a GLP-1

The review concludes that future research must establish evidence-based screening protocols, determine optimal glucose nadir cut-off values for diagnosis, and evaluate long-term outcomes for offspring exposed to maternal hypoglycemia

Medical Oversight How Each Program Monitors Your Progress Amazon One Medical: GLP-1 management integrated into ongoing primary care relationship Regular follow-up appointments with the same provider over time Integrated lab work and cardiovascular monitoring Clinician visibility into full health picture not just weight loss metrics Dose adjustments handled through scheduled consultations with continuity provider Strongest medical oversight model currently available in the GLP-1 telehealth market Direct Meds: Licensed provider review at intake and prescription issuance Nurse support included throughout treatment period Telehealth-based ongoing access for clinical questions Less integrated with broader primary care than Amazon's model Appropriate for patients whose primary care relationship exists separately The bottom line on oversight: Amazon One Medical offers a meaningfully more integrated and clinically comprehensive oversight model

Read professional profile Dr Rimas Geiga Medical doctor with a special interest in nutritional sciences, dietology, metabolic health and evidence based preventative care